Search

everythinglearnresearchcommunity

for

Search:↓

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Researchers found specific genes in the part of hair follicles that could help treat hair disorders.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

New steroids were effective in blocking male hormone receptors in hamster prostates.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

Dutasteride and finasteride affect different cell types differently.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Physical activity, height, and smoking affect prostate cancer risk.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Cyclosporine A may help treat hair loss by blocking a protein that inhibits hair growth.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Wnt5a may slow down hair growth in mice.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

Prolactin and TGF-β receptor blockers might help treat hair loss.

Vitamin D3 and parathyroid hormone-related peptide may have important uses in skin treatments.

Mitochondrial problems in diabetic nerve damage might cause pain by lowering the production of certain nerve-related steroids.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.